Stay updated on Masitinib Efficacy and Safety in ALS Clinical Trial
Sign up to get notified when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.

Latest updates to the Masitinib Efficacy and Safety in ALS Clinical Trial page
- Check4 days agoChange DetectedThe NIH website transition notice about terminology and related updates no longer appears above the ClinicalTrials.gov 403 error page.SummaryDifference1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page remains a 403 Forbidden error.SummaryDifference0.2%

- Check18 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434.SummaryDifference1%

- Check25 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, presenting an error screen and site chrome. This reflects an access issue or protective page behavior rather than a substantive update to the study information.SummaryDifference19%

Stay in the know with updates to Masitinib Efficacy and Safety in ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.